We are live on ! Find out more
IGC icon

IGC Pharma
IGC

4 hedge funds and large institutions have $23K invested in IGC Pharma in 2015 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 1

12% less capital invested

Capital invested by funds: $26K → $23K (-$3K)

33% less funds holding

Funds holding: 6 → 4 (-2)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 2

Holders
4
Holders Change
-2
Holders Change %
-33.33%
% of All Funds
0.11%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
2
Reduced
1
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
VKH
Virtu KCG Holdings
New York
+$15.9K
2
Citadel Advisors
Citadel Advisors
Florida
+$2.18K

Top Sellers

Rank Fund Capital Flow
1
UBS Group
UBS Group
Switzerland
-$2.02K
2
Bank of America
Bank of America
North Carolina
-$1K
Name Holding Trade Value Shares
Change 		Change in
Stake
VKH
1
Virtu KCG Holdings
New York
$16K +$15.9K +58,540 +232%
Citadel Advisors
2
Citadel Advisors
Florida
$6K +$2.18K +8,036 +35%
UBS Group
3
UBS Group
Switzerland
$1K -$2.02K -7,439 -64%
Bank of America
4
Bank of America
North Carolina
– -$1K -2,000 Closed

IGC Hedge Fund Activity: Q3 2015 in Review

4 of the 3,582 institutional investors tracked by Wall St. Rank reported a position in IGC Pharma (IGC) for Q3 2015, worth a combined $23K — down 12% from $26K a quarter earlier.

Sellers outnumbered buyers: 2 funds closed out of IGC and 0 opened new positions — a net loss of 2 holders — while 1 trimmed existing stakes and 2 added.

The largest buyer was Virtu KCG Holdings, adding an estimated $15.9K. The largest seller was UBS Group, cutting an estimated $2.02K.

  • 4 institutional investors held IGC Pharma (IGC) as of Q3 2015, down from 6 in Q2 2015.
  • Funds reported $23K of IGC Pharma stock for Q3 2015, down 12% quarter-over-quarter.
  • 0 funds opened new IGC Pharma positions in Q3 2015 and 2 closed out, a net change of -2 holders.
  • The largest IGC Pharma buyer in Q3 2015 was Virtu KCG Holdings, an estimated $15.9K added.
  • The largest IGC Pharma seller in Q3 2015 was UBS Group, an estimated $2.02K sold.

Based on aggregated 13F filings for Q3 2015.